• Prescribing information links at bottom of page
Image of hands holding the World with a green background

Flixotide Accuhaler packs - now all under £5.00

Providing an affordable, low carbon option for appropriate patients with asthma who need an inhaled corticosteroid

Flixotide Accuhaler is low carbon and now cheaper than the most commonly prescribed MDI and DPI ICS brands1

Please consult product SmPCs for specific indications and dosing regimens

Brand BTS/SIGN Adult Dose2 List price 30 day cost
Low dose2
Flixotide 100 Accuhaler 60 dose 1 puff BD £4.02 £4.02
Pulmicort 100mcg Turbohaler 200 dose 2 puffs BD £14.25 £8.55
Pulmicort 200mcg Turbohaler 100 dose 1 puff BD £14.25 £8.55
Clenil Modulite 100mcg 200 dose 2 puffs BD  £7.42 £4.45
Qvar MDI 50mcg 200 dose 2 puffs BD £7.87 £4.72
Medium dose2
Flixotide 250mcg Accuhaler 60 dose 1 puff BD £4.23 £4.23
Pulmicort 200mcg Turbohaler 100 dose 2 puffs BD £14.25 £17.10
Pulmicort 400mcg Turbohaler 50 dose 1 puff BD £14.25 £17.10
Clenil Modulite 200mcg 200 dose 2 puffs BD £16.17 £9.70
Qvar MDI 100mcg 200 dose 2 puffs BD £17.21 £10.33
High dose2
Flixotide 500 Accuhaler 1 puff BD £4.73 £4.73
Pulmicort 400mcg Turbohaler  2 puffs BD £14.25 £34.20
Clenil Modulite 250mcg  2 puffs BD £16.29 £9.77
Clenil Modulite 250mcg  4 puffs BD £16.29 £19.55
Qvar MDI 100mcg 200 dose 4 puffs BD £17.21 £20.65

In order to calculate which brands are commonly prescribed, where a brand has more than one strength pack, the pack volumes have been added together to give total brand volume

The price of three Flixotide Accuhaler packs have been significantly reduced to enable more affordable low carbon ICS prescribing

Bar chart showing the pre and post 1st August 2022 prices of the Flixotide Accuhaler packs.  For Flixotide 500mcg Accuhaler pack one bar shows the pre-1st August price of £43.37 and one bar shows the post-1st August price of £4.73.  For the  Flixotide 250mcg Accuhaler pack one bar shows the pre-1st August price of £25.51 and one bar shows the post-1st August price of £4.23.  For the Flixotide 100mcg Accuhaler pack one bar shows the pre-1st August price of £8.00 and one bar shows the post-1st August price of £4.02.  For the Flixotide 50mcg Accuhaler both bars show a price of £4.00 i.e. no change in price after 1st August 2022

Flixotide Accuhaler Indication3

Flixotide Accuhaler offers preventative treatment for asthma.

For Adults: Prophylactic management in mild asthma for patients requiring intermittent symptomatic bronchodilator asthma medication on a regular daily basis; prophylactic management in moderate asthma for patients with unstable or worsening asthma despite prophylactic therapy or bronchodilator alone; prophylactic management in severe asthma for patients with severe chronic asthma and those who are dependent on systemic corticosteroids for adequate control of symptoms.

For children: Any child who requires prophylactic medication for asthma, including patients not controlled on currently available prophylactic medication.

Dosing4

Adults and Children over 16 years of age: 

Mild asthma

  • The usual starting dose is 100 micrograms twice a day 
Picture of a Flixotide (fluticasone propionate) 100mcg Accuhaler device

Moderate to severe asthma

  • The usual starting dose is 250 to 500 micrograms twice a day
  • The most taken should be 1000 micrograms twice a day
Picture of a Flixotide (fluticasone propionate) 250mcg Accuhaler device &  Picture of a Flixotide (fluticasone propionate) 500mcg Accuhaler device

Children (4 to 16 years of age):

  • The usual starting dose is 50 micrograms twice a day
  • The most taken should be 200 micrograms twice a day
  • Flixotide Accuhaler 250 micrograms and Flixotide Accuhaler 500 micrograms are not recommended for children 16 years and under
Picture of a Flixotide (fluticasone propionate) 50mcg Accuhaler device

Be proactive, control asthma: resources to help you to support patients

Choose Accuhaler, reduce carbon

References

  1. IQVIA prescribed data volume MAT April 2022
  2. BTS/SIGN Asthma Guideline 2019. Table 12
  3. Flixotide Accuhaler SPC
  4. Flixotide Accuhaler Patient Information Leaflet (PIL)
  5. Nathan RA et al. J Allergy Clin Immunol 2004;113:59-65

 

Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellowcard in the Google Play or Apple App store. Adverse events should also be reported to GlaxoSmithKline on 0800 221 441

© 2021 GSK group of companies or its licensor.
Trademarks are owned by or licensed to the GSK group of companies.
Third party trade marks are the property of their respective owners

July 2022 | PM-GB-FLP-WCNT-220002 (V1.0)